Abeona Therapeutics Inc. (0H7R.L)
USD 4.91
(1.42%)
USD 4.91
(1.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.53 USD | 49.9% |
| 2022 | -5.05 USD | 76.59% |
| 2021 | -21.57 USD | 5.1% |
| 2020 | -22.73 USD | 39.98% |
| 2019 | -37.87 USD | -27.04% |
| 2018 | -29.81 USD | -81.77% |
| 2017 | -16.40 USD | -2.5% |
| 2016 | -16.00 USD | -21.58% |
| 2015 | -13.16 USD | 96.55% |
| 2014 | -381.56 USD | -602.05% |
| 2013 | 76.00 USD | 111.73% |
| 2012 | -647.83 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.19 USD | 70.69% |
| 2024 Q1 | -1.16 USD | -78.46% |
| 2023 Q3 | -0.48 USD | 47.83% |
| 2023 FY | - USD | 49.9% |
| 2023 Q2 | -0.92 USD | -70.37% |
| 2023 Q4 | -0.65 USD | -35.42% |
| 2023 Q1 | -0.54 USD | -750.39% |
| 2022 FY | - USD | 76.59% |
| 2022 Q3 | -1.48 USD | -3.5% |
| 2022 Q2 | -1.43 USD | 60.17% |
| 2022 Q1 | -3.59 USD | 67.8% |
| 2022 Q4 | -0.06 USD | 95.71% |
| 2021 Q2 | -3.94 USD | 7.29% |
| 2021 Q4 | -11.15 USD | -519.44% |
| 2021 Q3 | -1.80 USD | 54.31% |
| 2021 Q1 | -4.25 USD | 0.23% |
| 2021 FY | - USD | 5.1% |
| 2020 Q3 | -1.95 USD | 44.44% |
| 2020 Q2 | -3.51 USD | 73.08% |
| 2020 FY | - USD | 39.98% |
| 2020 Q1 | -13.04 USD | -73.87% |
| 2020 Q4 | -4.26 USD | -118.46% |
| 2019 Q2 | -12.22 USD | -26.37% |
| 2019 Q4 | -7.50 USD | 14.09% |
| 2019 Q3 | -8.73 USD | 28.56% |
| 2019 FY | - USD | -27.04% |
| 2019 Q1 | -9.67 USD | -6.15% |
| 2018 Q1 | -5.59 USD | -20.73% |
| 2018 Q3 | -8.59 USD | -32.77% |
| 2018 Q4 | -9.11 USD | -6.05% |
| 2018 FY | - USD | -81.77% |
| 2018 Q2 | -6.47 USD | -15.74% |
| 2017 Q3 | -3.31 USD | 35.6% |
| 2017 Q2 | -5.14 USD | -57.67% |
| 2017 Q1 | -3.26 USD | 29.44% |
| 2017 FY | - USD | -2.5% |
| 2017 Q4 | -4.63 USD | -39.88% |
| 2016 Q3 | -1.97 USD | 61.45% |
| 2016 FY | - USD | -21.58% |
| 2016 Q4 | -4.62 USD | -134.52% |
| 2016 Q2 | -5.11 USD | -20.8% |
| 2016 Q1 | -4.23 USD | -137.64% |
| 2015 Q4 | -1.78 USD | 62.76% |
| 2015 Q2 | -4.00 USD | -60.0% |
| 2015 Q1 | -2.50 USD | 95.09% |
| 2015 FY | - USD | 96.55% |
| 2015 Q3 | -4.78 USD | -19.5% |
| 2014 FY | - USD | -602.05% |
| 2014 Q4 | -50.93 USD | 50.92% |
| 2014 Q2 | -631.56 USD | -725.46% |
| 2014 Q3 | -103.76 USD | 83.57% |
| 2014 Q1 | -76.51 USD | 11.45% |
| 2013 FY | - USD | 111.73% |
| 2013 Q1 | 162.51 USD | -83.44% |
| 2013 Q2 | 42.50 USD | -73.85% |
| 2013 Q3 | -44.25 USD | -204.12% |
| 2013 Q4 | -86.40 USD | -95.25% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | 981.50 USD | 0.0% |